Osteoarthritis Implementing NICE guidance 2008 NICE clinical guideline 59.

Slides:



Advertisements
Similar presentations
HealthPartners Medical Group
Advertisements

Unstable angina and NSTEMI
Inadvertent perioperative hypothermia
Implementing NICE guidance
Surgical site infection
Attention deficit hyperactivity disorder Implementing NICE guidance 2008 NICE clinical guideline 72.
Depression in adults with a chronic physical health problem
Implementing NICE guidance
Pregnancy and complex social factors
Respiratory tract infections - antibiotic prescribing
Irritable bowel syndrome in adults
Metastatic spinal cord compression
Type 2 diabetes Implementing NICE guidance 2009 NICE clinical guideline 87.
Hip and Arthritis: Treatment Alternatives To Remain Active
First MTP Osteoarthritis
Low back pain Implementing NICE guidance 2009 NICE clinical guideline 88.
ARTHROSCOPIC FEATURES Chondromalacia Advanced chondromalacia Cartilage eburnation.
Management of Rheumatoid arthritis, Osteoarthritis & Gout Dr. Eoin Casey MD FRCPI, FRCP.
Urinary incontinence in women October Changing clinical practice NICE guidelines are based on the best available evidence The Department of Health.
OSTEOARTHRITIS OSTEOARTHROSIS DEGENERATIVE JOINT DISEASE
Case Presentation 65 yr, male C/O right knee pain, stiffness Can not walk more than 10 mts Can not sleep at night Walks with frame 30/12//20121.
Nichola Caiger, F1.  To refresh your knowledge of: ◦ S/S of OA ◦ Risk factors for OA ◦ Investigations ◦ Management of OA ◦ Complications of OA.
All About Rheumatoid Arthritis
Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence Implementing NICE guidance February 2011 NICE clinical.
All About Osteoarthritis
By Amy Lovern, RN, BSN.  Osteoarthritis (OA) is one of the oldest and most common forms of arthritis.  Known as the “wear and tear” kind of arthritis.
By Dan Alston.  Osteoarthritis “refers to a clinical syndrome of joint pain accompanied by varying degrees of functional limitation and reduced quality.
Dr. Alan G. Lewis Eastern Oklahoma Orthopedic Center MKT Rev B.
Implementing NICE guidance
Osteoarthritis By: Tilly Paterson and Amanda Elsaesser.
Implementing NICE guidance
3/4/03Steven Stoltz, M.D. Back Pain 2 nd most common cause for office visit 60-80% of population will have lower back pain at some time in their lives.
Implementing NICE guidance
Koco Eaton, M.D. Team Physician – Tampa Bay Rays and Tampa Bay Buccaneers.
Osteoarthritis. Mr. P 45y Plumber BL knee pains OA diagnosed on XR.
OSTEOARTHRITIS. Osteoarthritis (OA) is a common, degenerative disease, which is characterized by local degeneration of joint cartilage and new bone formation.
Osteoarthritis Dr. Faik Altıntaş Yeditepe Üniversitesi Tıp Fakültesi
Osteoarthritis.  Osteoarthritis OA is a degenerative disease of diarthrodial ( synovial ) joints, characterized by  Breakdown of articular cartilage.
“Helping Osteoarthritis Patients Regain Mobility”.
Osteoarthritis (OA) Dr. Timothy Payne, MD. What is Osteoarthritis? Osteoarthritis is primarily a non- inflammatory degenerative disorder of moveable joints.
No MRI Needed Osteoarthritic kneeHealthy knee. Burden of Disease 39.4 million visits to physicians offices 750,000 hospitalizations OA cost $125 billion/year.
ARTHRITIS Aaron Calilap Cariane Matela Tyra Wiggins.
Back Pain in General Practice Dr Chris Monella GPSI.
Rivaroxaban for Prevention of Venous Thromboembolism After Total Knee Arthroplasty: Impact on Healthcare Costs Based on the RECORD3 Study Kwong L, Lees.
Implementing NICE guidance 2011 NICE clinical guideline 113 Generalised anxiety disorder in adults.
Knee Sam and Matt. Disease: Osteoarthritis Knee with Osteoarthritis.
Osteoarthritis ---About osteoarthritis cause, treatment and conclusion. ---By Yanhong, Sharmila and Jiah.
An unpleasant sensory or emotional experience associated with actual or potential tissue damage The World Health Organization (WHO) has stated that pain.
Heavy menstrual bleeding Implementing NICE guidance January 2007 NICE clinical guideline 44.
East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast NSAIDS – Efficacy and Safety Expert speaker.
Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57) Last modified January 2015.
Medicines adherence Implementing NICE guidance 2009 NICE clinical guideline 76.
Induction of labour Implementing NICE guidance 2 nd edition – March 2012 NICE clinical guideline 70.
Support for implementing NICE guidance: Unstable angina and NSTEMI Unstable angina and NSTEMI, CG94, rd Edition March 2014.
The Knee Andrew Pearse Consultant Trauma and Orthopaedics Worcestershire Acute Hospitals NHS Trust.
Alcohol dependence and harmful alcohol use NICE quality standard August 2011.
NHS Specialist Pharmacy Service NSAIDS – efficacy and safety Expert speaker Slide set Key content from the NPC NSAIDS QIPP slides is gratefully acknowledged.
AN ALGORITHM OF THE MANAGEMENT OF KNEE OSTEOARTHRITIS (OA) Prof. Matjaž Sajovic MD. PhD Department for Orthopedics and Sports Trauma Surgery General Teaching.
Hip & Knee OA: 5 Pearls to Delay the Dreaded Total Joint Replacement
Loyola-Provident-Cook County Family Medicine Residency
OSTEOARTHRITIS DEGENERATIVE JOINT DISEASE
Implementing NICE guidance
54 Osteoarthritis.
Making Decisions With Your Osteoarthritis Patients
Joint, Connective Tissue, and Bone Disorders and Management
بسم الله الرحمن الرحیم.
Flatfoot in Adults.
Non-Malignant Chronic Pain Management
Presentation transcript:

Osteoarthritis Implementing NICE guidance 2008 NICE clinical guideline 59

What this presentation covers Background Holistic assessment and targeting treatment Key priorities for implementation -Core treatment -Adjuncts to core therapy Costs and savings Discussion Find out more

Background Osteoarthritis refers to a clinical syndrome of joint pain accompanied by varying degrees of functional limitation and reduced quality of life. It is the most common form of arthritis and one of the leading causes of pain and disability worldwide. It is not caused by ageing and does not necessarily deteriorate. It is a metabolically active repair process which is slow and can result in a structurally altered but symptom-free joint.

Holistic assessment A holistic approach to osteoarthritis assessment and management is needed. Healthcare professionals should assess the effect of osteoarthritis on the individual’s function, quality of life, occupation, mood, relationships, and leisure activities.

Targeting treatment education, advice, information access strengthening exercise aerobic fitness training weight loss if overweight/obese topical NSAIDs paracetamol supports and braces intra-articular corticosteroid injections opioids joint arthroplasty oral NSAIDs including COX-2 inhibitors TENS local heat and cold capsaicin manual therapy (manipulation and stretching) assistive devices shock-absorbing shoes or insoles

Core treatment Exercise should be a core treatment for people with osteoarthritis, irrespective of age, comorbidity, pain severity or disability. Exercise should include: local muscle strengthening, and general aerobic fitness.

Healthcare professionals should consider offering paracetamol for pain relief in addition to core treatment; regular dosing may be required. Paracetamol and/or topical non-steroidal anti- inflammatory drugs (NSAIDs) should be considered ahead of oral NSAIDs, cyclo-oxygenase 2 (COX-2) inhibitors or opioids. Adjunct to core therapy: paracetamol

Healthcare professionals should consider offering topical NSAIDs for pain relief in addition to core treatment for people with knee or hand osteoarthritis. Topical NSAIDs and/or paracetamol should be considered ahead of oral NSAIDs, COX-2 inhibitors or opioids. Adjunct to core therapy: topical treatments

When offering treatment with an oral NSAID/COX-2 inhibitor, the first choice should be either a standard NSAID or a COX-2 inhibitor (other than etoricoxib 60 mg). In either case, these should be co-prescribed with a proton pump inhibitor (PPI), choosing the one with the lowest acquisition cost. Adjunct to core therapy: Oral NSAID/Cox-2 inhibitors

Referral for joint replacement surgery should be considered for people with osteoarthritis who experience joint symptoms that have a substantial impact on their quality of life and are refractory to non-surgical treatment. Referral should be made before there is prolonged and established functional limitation and severe pain. Adjunct to core therapy: referral criteria for surgery

Referral for arthroscopic lavage and debridement should not be offered as part of treatment for osteoarthritis, unless the person has knee osteoarthritis with a clear history of mechanical locking (not gelling, ‘giving way’ or X-ray evidence of loose bodies). Adjunct to core therapy: invasive treatments for knee osteoarthritis

Costs and savings per 100,000 population Recommendations with significant costs Costs (£ per year) Topical NSAIDs18,000 Proton pump inhibitors23,000 Estimated cost of implementation41,000 Recommendations with significant savings Savings (£ per year) Invasive treatments– 52,000 Oral NSAIDS-5,000 Estimated saving of implementation– 57,000 Total net saving of implementing the guideline-16,000

Discussion Which core recommendations present the most challenges for local practice? Offering topical NSAIDs before oral dosage forms is likely to be a change to established clinical patterns. What needs to happen and by when? What changes do we need to make in relation to surgical services and the way we commission them? What are the next steps to be considered in implementing the core treatments locally?

Find out more Visit for: Other guideline formats Costing report and template Audit support